Analysts Set Expectations for ELEV Q2 Earnings
Elevation Oncology, Inc. (NASDAQ:ELEV – Free Report) – Investment analysts at Leerink Partnrs issued their Q2 2025 EPS estimates for Elevation Oncology in a research note issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens forecasts that the company will post earnings per share of ($0.20) for the quarter. The consensus estimate for Elevation […]
Elevation Oncology, Inc. (NASDAQ:ELEV – Free Report) – Investment analysts at Leerink Partnrs issued their Q2 2025 EPS estimates for Elevation Oncology in a research note issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens forecasts that the company will post earnings per share of ($0.20) for the quarter. The consensus estimate for Elevation […]
